IDO1 and neoplasm: Previous literature has extensively investigated factors associated with the dormancy mechanisms, and indoleamine 2,3-dioxygenase 1 (IDO1) has been identified as one of the players [for a comprehensive review of molecular cues involved in tumour dormancy, see (6)].